Royal Marsden NHS Foundation Trust
Chelsea, United Kingdom
Cancer treatment center in London, England
203 Fulham Rd., London SW3 6JJ
About Royal Marsden NHS Foundation Trust
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
European Organisation for Research and Treatment of Cancer - EORTC
2
EMD Serono Research & Development Institute, Inc.
1
Pfizer
1
Royal Marsden NHS Foundation Trust
1
University of Oxford
1
Viralytics
1
Clinical Trials at Royal Marsden NHS Foundation Trust
During the past decade, Royal Marsden NHS Foundation Trust conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 1 clinical trials were completed, i.e. on
average, 25% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 1 clinical trials were completed. i.e. 50%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Modafinil for the Treatment of Fatigue in Lung Cancer V9.0
2009-02-01
2012-05-01
Completed
208
CVA21 and Pembrolizumab in NSCLC & Bladder Cancer (VLA-009 STORM/ KEYNOTE-200)
2013-12-18
2020-01-10
Completed
85
Study of Binimetinib + Nivolumab Plus or Minus Ipilimumab in Patients With Previously Treated Microsatellite-stable (MSS) Metastatic Colorectal Cancer With RAS Mutation
2017-10-18
2021-02-25
Completed
75
Pembrolizumab and Hypofractionated Stereotactic Radiotherapy in Patients With Malignant Pleural Mesothelioma
2021-01-26
2024-08-01
Recruiting
18
A Study of Xevinapant (Debio 1143) in Combination With Platinum-Based Chemotherapy and Standard Fractionation Intensity-Modulated Radiotherapy in Participants With Locally Advanced Squamous Cell Carcinoma of the Head and Neck, Suitable for Definitive Chemoradiotherapy (TrilynX)
2020-08-07
2027-04-30
Active, not recruiting
730
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Royal Marsden NHS Foundation Trust" #1 sponsor was "European Organisation for Research and Treatment of Cancer - EORTC" with 2 trials, followed by "EMD Serono Research & Development Institute, Inc." with 1 trials
sponsored, "Pfizer" with 1 trials sponsored, "Royal Marsden NHS Foundation Trust" with 1 trials sponsored and "University of Oxford"
with 1 trials sponsored. Other sponsors include -4 different institutions and
companies that sponsored additional 6 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Royal Marsden NHS Foundation Trust"
#1 collaborator was "Merck Sharp & Dohme LLC" with 2 trials as a collaborator, "Boehringer Ingelheim" with 1 trials as a collaborator, "Bristol-Myers Squibb" with 1 trials as a collaborator, "GORTEC (Head and Neck Oncology and Radiotherapy Group)" with 1 trials as a collaborator and "Merck KGaA, Darmstadt, Germany" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were
collaborators in the rest 6 trials.
Clinical Trials Conditions at Royal Marsden NHS Foundation Trust
According to Clinical.Site data, the most researched conditions in "Royal Marsden NHS Foundation Trust" are
"Advanced Malignant Pleural Mesothelioma" (1 trials), "Bladder Cancer" (1 trials), "Carcinoma, Non-Small-Cell Lung" (1 trials), "Dedifferentiated Liposarcoma" (1 trials) and "MSS" (1 trials). Many other conditions were trialed in "Royal Marsden NHS Foundation Trust" in a lesser frequency.
Clinical Trials Intervention Types at Royal Marsden NHS Foundation Trust
Most popular intervention types in "Royal Marsden NHS Foundation Trust" are "Drug" (6 trials), "Radiation" (2 trials) and "Biological" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (2 trials), "CVA21/pembrolizumab" (1 trials), "Cabazitaxel" (1 trials), "Cisplatin" (1 trials) and "Ifosfamide" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Royal Marsden NHS Foundation Trust
The vast majority of trials in "Royal Marsden NHS Foundation Trust" are
7 trials for "All" genders.
Clinical Trials Status at Royal Marsden NHS Foundation Trust
Currently, there are NaN active trials in "Royal Marsden NHS Foundation Trust".
undefined are not yet recruiting,
1 are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 4 completed trials in Royal Marsden NHS Foundation Trust,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Royal Marsden NHS Foundation Trust, 2 "Phase 1"
clinical trials were conducted, 3 "Phase 2" clinical
trials and 1 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 0 trials that are defined as “Not Applicable".